The PROPKD score: A new algorithm to predict renal survival in autosomal dominant polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 27, Issue 3, 2016, Pages 942-951

  Gall, Emilie Cornec Le ^a,b,c   Audrézet, Marie Pierre ^a,d   Rousseau, Annick ^d   Hourmant, Maryvonne ^e   Renaudineau, Eric ^f   Charasse, Christophe ^g   Morin, Marie Pascale ^h   Moal, Marie Christine ^a   Dantal, Jacques ⁱ   Wehbe, Bassem ^j   Perrichot, Régine ^k   Frouget, Thierry ^l   Vigneau, Cécile ^l   Potier, Jérôme ^m   Jousset, Philippe ⁿ   Guillodo, Marie Paule ^o   Siohan, Pascale ^p   Terki, Nazim ^q   Sawadogo, Théophile ^r   Legrand, DIdier ^s   Menoyo Calonge, Victorio ^m   Benarbia, Seddik ⁿ   Besnier, Dominique ^t   Longuet, Hélène ⁿ   Férec, Claude ^a,b,c,o   Le Meur, Yannick ^a,b   more..

^a BREST UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^c French Blood Agency   (France)

^d LIMOGES UNIVERSITY HOSPITAL   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f HÔPITAL BROUSSAIS   (France)

^g Yves Le Foll Hospital   (France)

^h RENNES UNIVERSITY HOSPITAL   (France)

ⁱ Laënnec Hospital   (France)

^j Vannes Hospital   (France)

^k Department of Physical Medicine and Rehabilitation   (France)

^l AUB Santé   (France)

^m Hemodialysis Unit   (France)

ⁿ Lorient Hospital   (France)

^o AUB Santé   (France)

^p ECHO Dialysis Unit   (France)

^q AUB Santé   (France)

^r Saint Nazaire Hospital   (France)

^s UNIVERSITY HOSPITAL OF TOURS   (France)

^t ETABLISSEMENT FRANÇAIS DU SANG   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

POLYCYSTIN 1; POLYCYSTIN 2; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIC KIDNEY DISEASE 2 PROTEIN; POLYCYSTIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE COURSE; END STAGE RENAL DISEASE; FEMALE; GENE MUTATION; GROUPS BY AGE; HEMODIALYSIS; HEREDITY; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROPKD SCORE; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; URINARY TRACT DISEASE ASSESSMENT; ALGORITHM; COMPLICATION; GENETICS; GENOTYPE; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC; MUTATION; ONSET AGE; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RISK FACTOR; SURVIVAL RATE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALGORITHMS; AREA UNDER CURVE; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GENOTYPE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUTATION; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RISK FACTORS; ROC CURVE; SEX FACTORS; SURVIVAL RATE; TRPP CATION CHANNELS; YOUNG ADULT;

EID: 84959900311     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015010016     Document Type: Article

References (24)

1. Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 369: 1287-1301, 2007
2. Shaw C, Simms RJ, Pitcher D, Sandford R: Epidemiology of patients in England andWales with autosomal dominant polycystic kidney disease and end-stage renal failure. Nephrol Dial Transplant 29: 1910-1918, 2014
3. Cornec-LeGall E, AudrézetM-P,Meur YL, Chen J-M, Férec C: Genetics and pathogenesis of autosomal dominant polycystic kidney disease: 20 years on. Hum Mutat 35: 1393-1406, 2014
4. Cornec-Le Gall E, Audrézet M-P, Chen J-M, Hourmant M, Morin M-P, Perrichot R, Charasse C,Whebe B, Renaudineau E, Jousset P, Guillodo M-P, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y: Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24: 1006-1013, 2013
5. Zerres K, Rudnik-Schöneborn S, Deget F: Childhood onset autosomal dominant polycystic kidney disease in sibs: Clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie. J Med Genet 30: 583-588, 1993
6. Fick GM, Johnson AM, Strain JD, Kimberling WJ, Kumar S, Manco-Johnson ML, Duley IT, Gabow PA: Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3: 1863-1870, 1993
7. Torra R, Badenas C, Pérez-Oller L, Luis J, Millán S, Nicolau C, Oppenheimer F, Milà M, Darnell A: Increased prevalence of polycystic kidney disease type 2 among elderly polycystic patients. Am J Kidney Dis 36: 728-734, 2000
8. Harris PC, Torres VE: Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest 124: 2315-2324, 2014
9. Walz G, Budde K, Mannaa M, Nürnberger J, Wanner C, Sommerer C, Kunzendorf U, Banas B, HörlWH,Obermüller N, Arns W, Pavenstädt H, Gaedeke J, Büchert M, May C, Gschaidmeier H, Kramer S, Eckardt K-U: Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med 363: 830-840, 2010
10. Serra AL, Poster D, Kistler AD, Krauer F, Raina S, Young J, Rentsch KM, Spanaus KS, Senn O, Kristanto P, Scheffel H, Weishaupt D, Wüthrich RP: Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med 363: 820-829, 2010
11. Caroli A, Perico N, Perna A, Antiga L, Brambilla P, Pisani A, Visciano B, Imbriaco M, Messa P, Cerutti R, Dugo M, Cancian L, Buongiorno E, De Pascalis A, Gaspari F,Carrara F, RubisN, Prandini S, Remuzzi A, Remuzzi G, Ruggenenti P; ALADIN study group: Effect of longactingsomatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 382: 1485-1495, 2013
12. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators: Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367: 2407-2418, 2012
13. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP; CRISP Investigators: Volume progression in polycystic kidney disease. N Engl J Med 354: 2122-2130, 2006
14. Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ: Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 7: 479-486, 2012
15. Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, GranthamJJ,Mrug M, HoganMC, El-Zoghby ZM, Harris PC, Erickson BJ, King BF, Torres VE; the CRISP Investigators: Imaging classification of autosomal dominant polycystic kidney disease: A simplemodel for selecting patients for clinical trials. J Am Soc Nephrol 26: 160-172, 2014
16. Audrézet M-P, Cornec-Le Gall E, Chen J-M, Redon S, Quéré I, Creff J, Bénech C, Maestri S, Le Meur Y, Férec C: Autosomal dominant polycystic kidney disease: Comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat 33: 1239-1250, 2012
17. Rossetti S, Hopp K, Sikkink RA, Sundsbak JL, Lee YK, Kubly V, Eckloff BW,Ward CJ,Winearls CG, Torres VE, Harris PC: Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. J Am Soc Nephrol 23: 915-933, 2012
18. Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC; CRISP Consortium: Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18: 2143-2160, 2007
19. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, SanMillan JL, Gibson R, Breuning M, Peters D, Ravine D: Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20: 205-212, 2009
20. Schrier RW, Brosnahan G, CadnapaphornchaiMA, ChoncholM, Friend K, Gitomer B, Rossetti S: Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol 25: 2399-2418, 2014
21. Johnson AM, Gabow PA: Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 8: 1560-1567, 1997
22. Harrell FE Jr, Lee KL,Mark DB:Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387, 1996
23. Heagerty PJ, Zheng Y: Survival model predictive accuracy and ROC curves. Biometrics 61: 92-105, 2005
24. Blanche P, Dartigues J-F, Jacqmin-Gadda H: Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med 32: 5381-5397, 2013